The National Medical Products Administration (NMPA) recently issued a circular, stating that local medical products’ administrations must conduct inspections of medical devices in accordance with Appendix I and Appendix II of the National Plan for Product Sampling Inspection of Medical Devices... More
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service is seeking input from interested parties by 5 August on a proposed new rule regarding the regulation of certain genetically engineered organisms. More
In the 19th century, Hong Kong made an indelible mark on the world of medicine – it was here that the lifecycle of one of humanity’s greatest scourges, malaria, was discovered, opening the way to control and cure.
The Hong Kong Sanatorium and Hospital’s oncology department has been accredited as a duly-qualified clinical drug trial institution and may now undertake mainland-valid National Medical Products Administration (NMPA) approved clinical drug trials on behalf of applicants seeking official drug registration. More
The Outline Development Plan for Greater Bay Area fosters close cooperation in medical and healthcare resources. The government departments are formulating policies, such as cross-border customs-clearance measures to facilitate the circulation of research samples and genetic resources. Hong Kong has biotech talents, free flow of financial resources, professional services and intellectual-property protection which help the biomedicine industry in the GBA increase competitiveness. More
The world has been on constant alert when it comes to pandemics and epidemics, particularly in cities where crowded living conditions can often accelerate the spread of any infection outbreak. Hong Kong certainly possesses the tools needed to protect itself and the mainland China from any such risks. Hong Kong’s researchers and technology companies ensure the Bay Area is well prepared to deal with any emerging infectious diseases. More
Hong Kong is a significant hub for cooperation in R&D and advanced biomedical services in the Greater Bay Area and beyond. The city can fill the gap between mainland China and overseas in the field of genetic and biomedical information. It can become a bridgehead for biomedical companies looking to extend their research and services from the Greater Bay Area to the Belt and Road and other overseas markets. More